Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study
- PMID: 12697884
- DOI: 10.1200/JCO.2003.05.116
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study
Abstract
Purpose: To determine whether preradiotherapy (RT) chemotherapy would improve outcome for Chang stage M0-1 medulloblastoma when compared with RT alone. Chemotherapy comprised vincristine 1.5 mg/m2 weekly for 10 weeks and four cycles of etoposide 100 mg/m2 daily for 3 days, and carboplatin 500 mg/m2 daily for 2 days alternating with cyclophosphamide 1.5 g/m2.
Patients and methods: Patients aged 3 to 16 years inclusive were randomly assigned to receive 35 Gy craniospinal RT with a 20 Gy posterior fossa boost, or chemotherapy followed by RT.
Results: Of 217 patients randomly assigned to treatment, 179 were eligible for analysis (chemotherapy + RT, 90 patients; RT alone, 89 patients). Median age was 7.67 years, and median follow-up was 5.40 years. Overall survival (OS) at 3 and 5 years was 79.5% and 70.7%, respectively. Event-free survival (EFS) at 3 and 5 years was 71.6% and 67.0%, respectively. EFS was significantly better for chemotherapy and RT (P =.0366), with EFS of 78.5% at 3 years and 74.2% at 5 years compared with 64.8% at 3 years and 59.8% at 5 years for RT alone. There was no statistically significant difference in 3-year and 5-year OS between the two arms (P =.0928). Multivariate analysis identified use of chemotherapy (P =.0248) and time to complete RT (P =.0100) as having significant effect on EFS.
Conclusion: This is the first large multicenter randomized study to demonstrate improved EFS for chemotherapy compared with RT alone. It is anticipated that this regimen could reduce ototoxicity and nephrotoxicity compared with cisplatin-containing schedules. The importance of avoiding interruptions to RT has been confirmed.
Similar articles
-
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1184-93. doi: 10.1016/j.ijrobp.2003.08.010. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001263 Clinical Trial.
-
Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.Eur J Cancer. 2005 Mar;41(5):727-34. doi: 10.1016/j.ejca.2004.12.017. Epub 2005 Jan 18. Eur J Cancer. 2005. PMID: 15763649 Clinical Trial.
-
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):269-79. doi: 10.1016/s0360-3016(99)00369-7. Int J Radiat Oncol Biol Phys. 2000. PMID: 10661332 Clinical Trial.
-
Adult medulloblastoma: multiagent chemotherapy.Neuro Oncol. 2001 Jan;3(1):29-34. doi: 10.1093/neuonc/3.1.29. Neuro Oncol. 2001. PMID: 11305414 Free PMC article. Review.
-
Chemotherapy for children with medulloblastoma.Cochrane Database Syst Rev. 2015 Jan 1;1(1):CD006678. doi: 10.1002/14651858.CD006678.pub2. Cochrane Database Syst Rev. 2015. PMID: 25879092 Free PMC article. Review.
Cited by
-
Pediatric-Like Brain Tumors in Adults.Adv Tech Stand Neurosurg. 2024;50:147-183. doi: 10.1007/978-3-031-53578-9_5. Adv Tech Stand Neurosurg. 2024. PMID: 38592530 Review.
-
Postradiation platinum-etoposide in adult medulloblastomas: retrospective analysis of hematological toxicity.CNS Oncol. 2024 Jun 6;13(1):CNS107. doi: 10.2217/cns-2023-0029. Epub 2024 Mar 8. CNS Oncol. 2024. PMID: 38456492 Free PMC article.
-
Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches.Diagnostics (Basel). 2023 Dec 16;13(24):3680. doi: 10.3390/diagnostics13243680. Diagnostics (Basel). 2023. PMID: 38132264 Free PMC article. Review.
-
Risk-Adapted Treatment Strategies with Pre-Irradiation Chemotherapy in Pediatric Medulloblastoma: Outcomes from the Polish Pediatric Neuro-Oncology Group.Children (Basel). 2023 Aug 15;10(8):1387. doi: 10.3390/children10081387. Children (Basel). 2023. PMID: 37628386 Free PMC article.
-
Questions and answers in the management of children with medulloblastoma over the time. How did we get here? A systematic review.Front Oncol. 2023 Jun 29;13:1229853. doi: 10.3389/fonc.2023.1229853. eCollection 2023. Front Oncol. 2023. PMID: 37456257 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical